Kepos Capital’s Colgate-Palmolive CL Stock Holding History

Kepos Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-342	Closed	-$36K	–	81
2024 Q3	$36K	Sell	342 -55	-14%	-$5.61K	0.02%	170
2024 Q2	$39K	Sell	397 -60	-13%	-$5.54K	0.02%	173
2024 Q1	$41K	Sell	457 -100	-18%	-$8.47K	0.01%	199
2023 Q4	$44K	Buy	557 +12	+2%	+$902	0.01%	154
2023 Q3	$39K	Buy	545 +56	+11%	+$4.19K	0.01%	201
2023 Q2	$38K	Buy	+489	New	+$37.9K	0.01%	249
2022 Q4	$40K	Buy	+506	New	+$37.9K	0.01%	257
2019 Q3	–	Sell	-17,221	Closed	-$1.23M	–	325
2019 Q2	$1.23M	Buy	+17,221	New	+$1.22M	0.13%	152
2019 Q1	–	Sell	-109,021	Closed	-$6.49M	–	353
2018 Q4	$6.49M	Buy	109,021 +78,324	+255%	+$4.9M	0.5%	43
2018 Q3	$2.06M	Sell	30,697 -1,243	-4%	-$82.8K	0.11%	161
2018 Q2	$2.07M	Buy	+31,940	New	+$2.09M	0.11%	161
2018 Q1	–	Sell	-47,237	Closed	-$3.56M	–	288
2017 Q4	$3.56M	Buy	+47,237	New	+$3.45M	0.32%	94

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Kepos Capital's CL Position: Q4 2024 in Review

Kepos Capital sold out of Colgate-Palmolive (CL) in Q4 2024, closing a stake of 342 shares — an estimated $36K sold.

Kepos Capital first reported a position in CL in Q4 2017 and held it in 12 quarters. The position peaked at $6.49M in Q4 2018. 1,932 funds tracked by Wall St. Rank hold CL as of Q4 2024.

Kepos Capital reported no remaining Colgate-Palmolive position as of Q4 2024 after selling out during the quarter.
Kepos Capital sold 342 Colgate-Palmolive shares in Q4 2024, an estimated $36K.
Kepos Capital first reported a position in Colgate-Palmolive in Q4 2017 and held it in 12 quarters.
Kepos Capital's Colgate-Palmolive position peaked at $6.49M in Q4 2018.
1,932 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2024.

Based on Kepos Capital's 13F filing for Q4 2024, filed 11 Feb 2025.